Pilot evaluation of hypnotic medication during acute traumatic stress response

Area of Science:

• Psychiatry
• Sleep Medicine
• Trauma Research

Background:

• Secondary prevention of posttraumatic stress disorder (PTSD) is a research priority.
• Disrupted sleep is implicated in the development and persistence of PTSD.
• Acute PTSD symptoms, including disturbed sleep, occur within weeks of trauma exposure.

Purpose of the Study:

• To investigate the potential of early intervention for acute PTSD symptoms.
• To assess the effect of temazepam on sleep and PTSD severity in recent trauma survivors.

Main Methods:

• A small cohort of patients (n=4) with acute PTSD and disturbed sleep were treated.
• Temazepam, a benzodiazepine hypnotic, was administered for 5 nights, followed by a 2-night taper.
• Evaluations were conducted one week after medication discontinuation.

Main Results:

• Patients experienced improved sleep quality after temazepam treatment.
• A reduction in PTSD symptom severity was observed post-treatment.
• The intervention was associated with positive outcomes in sleep and PTSD symptoms.

Conclusions:

• Short-term temazepam administration may be a clinically useful approach for early PTSD intervention.
• Further systematic clinical trials are warranted to validate these findings.
• Targeting sleep disturbances could be a key strategy in PTSD secondary prevention.